Latest Cancer News

Longest Follow-Up to Date Shows Active Surveillance is Safe and Feasible (04-23-2014)
Results from the longest follow-up to date of active surveillance in patients with favorable or intermediate-risk prostate cancer indicate that the approach is safe and feasible for as long as 20 years... Continue Reading

Xtandi Shows Significant Benefit in Chemotherapy-Naïve, Metastatic, Hormone-Refractory Prostate Cancer (04-21-2014)
Xtandi® (enzalutamide) showed significant survival benefit in men with chemotherapy-naïve, metastatic, hormone-refractory prostate cancer, according to the results of a study presented at the 2014 European... Continue Reading

Viagra Associated with Increased Risk of Melanoma (04-18-2014)
Men who take by Viagra (sildenafil) are 84 percent more likely to develop melanoma than men who do not, according to the results of a study published in JAMA Internal Medicine. Melanoma is a potentially... Continue Reading

More Cancer News

Locations

COLCHESTER
Vermont Center for Cancer Medicine and Blood Disorders, Inc.
792 College Parkway, Suite 207
Colchester, Vermont   05446
TEL: (802) 655-3400
FAX: (802) 655-9170

ST ALBANS
Vermont Center for Cancer Medicine and Blood Disorders, Inc.
4 Crest Road,
St. Albans, VT 05478
TEL: (802) 524-0537
FAX: (802) 524-0538

MIDDLEBURY
Vermont Center for Cancer Medicine and Blood Disorders, Inc.
110 Porter Drive,
Middlebury, VT 05753
TEL: (802) 388-8977
FAX: (802) 388-8976